Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:06 pm Purchase |
2024-12-31 | 13G | Neuphoria Therapeutics Inc. NEUP |
Armistice Capital, LLC | 1,033,796 4.990% |
1,033,796 (New Position) |
Filing History |
| 2025-01-28 4:30 pm Purchase |
2025-01-24 | 13D | Neuphoria Therapeutics Inc. NEUP |
Apeiron Investment Group Ltd. | 72,618 4.500% |
72,618 (New Position) |
Filing History |
| 2024-11-14 3:25 pm Purchase |
2024-09-30 | 13G | Bionomics Limited BNOX |
Armistice Capital, LLC | 145,462 9.990% |
145,462 (New Position) |
Filing History |
| 2024-11-14 09:03 am Sale |
2024-09-30 | 13G | Bionomics Limited BNOX |
Lynx1 Capital Management LP | 8,245,095 3.200% |
-4,119,480 (-33.32%) |
Filing History |
| 2024-10-07 6:10 pm Purchase |
2024-10-03 | 13D | Bionomics Limited BNOX |
Apeiron Investment Group Ltd. | 23,040,875 8.900% |
23,040,875 (New Position) |
Filing History |
| 2024-02-14 4:00 pm Sale |
2023-12-31 | 13G | Bionomics Limited BNOX |
TANG CAPITAL PARTNERS LP | 0 0.000% |
-10,500,000 (Position Closed) |
Filing History |
| 2024-02-14 10:20 am Sale |
2023-12-31 | 13G | Bionomics Limited BNOX |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-14,174,157 (Position Closed) |
Filing History |
| 2024-02-14 09:18 am Sale |
2023-12-31 | 13G | Bionomics Limited BNOX |
Lynx1 Capital Management LP | 12,364,575 7.800% |
-533,400 (-4.14%) |
Filing History |
| 2024-02-14 06:45 am Sale |
2023-12-31 | 13G | Bionomics Limited BNOX |
Point72 Asset Management, L.P. | 4,965,000 4.000% |
-4,959,390 (-49.97%) |
Filing History |
| 2023-10-30 4:21 pm Purchase |
2023-09-29 | 13G | Bionomics Limited BNOX |
Lynx1 Capital Management LP | 12,897,975 8.200% |
12,897,975 (New Position) |
Filing History |
| 2023-10-10 4:00 pm Purchase |
2023-09-28 | 13G | Bionomics Limited BNOX |
TANG CAPITAL PARTNERS LP | 10,500,000 8.600% |
10,500,000 (New Position) |
Filing History |
| 2023-09-29 4:33 pm Purchase |
2023-09-28 | 13G | Bionomics Limited BNOX |
Point72 Asset Management, L.P. | 9,924,390 8.100% |
9,924,390 (New Position) |
Filing History |
| 2022-02-14 12:56 pm Purchase |
2021-12-31 | 13G | Bionomics Limited BNOX |
BIOTECHNOLOGY VALUE FUND L P | 14,174,157 13.000% |
14,174,157 (New Position) |
Filing History |
| 2021-12-30 4:31 pm Purchase |
2021-12-20 | 13D | Neuphoria Therapeutics Inc. NEUP |
Apeiron Investment Group Ltd. | 33,545,866 27.700% |
33,545,866 (New Position) |
Filing History |